1 0

    FDA Drug Approval, A070755, LITHIUM CITRATE

    FDA Drug Approval, A070755, LITHIUM CITRATE

    $149.00 USD
    $149.00 USD
    Sale Sold out

    Contents: Summary Basis of Approval

    ANDA: 070755
    Company: PAI HOLDINGS PHARM
    Drug Name: LITHIUM CITRATE
    Active Ingredients: LITHIUM CITRATE
    Strength: EQ 300MG CARBONATE/5ML
    Dosage Form/Route: SYRUP;ORAL
    Action Date: 05/21/1986
    Marketing Status: Discontinued
    Submission Classification: ORIG-1 TE Code: None

    NOTE: This document is not currently in our library. Upon purchase, we will request the document from the FDA FOIA office. Learn more about Fast-Track Requests here.

    View full details